Abstract
The generation of neuronal cells from stem cells obtained from adult bone marrow is of significant clinical interest in order to design new cell therapy protocols for several neurological disorders. The recent identification in adult bone marrow of stem cells derived from the neural crest stem cells (NCSC) might explain the neuronal phenotypic plasticity shown by bone marrow cells. However, little information is available about the nature of these cells compared to mesenchymal stem cells (MSC), including their similarities and differences. In this paper, using transcriptomic as well as proteomic technologies, we compared NCSC to MSC and stromal nestin-positive cells, all of them isolated from adult bone marrow. We demonstrated that the nestin-positive cell population, which was the first to be described as able to differentiate into functional neurons, was a mixed population of NCSC and MSC. More interestingly, we demonstrated that MSC shared with NCSC the same ability to truly differentiate into Tuj1-positive cells when co-cultivated with paraformaldehyde-fixed cerebellar granule neurons. Altogether, those results suggest that both NCSC and MSC can be considered as important tools for cellular therapies in order to replace neurons in various neurological diseases.
Electronic supplementary material
The online version of this article (doi:10.1007/s00018-012-0937-1) contains supplementary material, which is available to authorized users.
Keywords: Neural crest stem cells, Mesenchymal stem cells, Adult bone marrow, Cell fate, Microarray
Introduction
Symptoms in human neurological disorders such as Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, multiple sclerosis (MS), stroke, and spinal cord injury are a consequence of a loss of neurons and glial cells in the brain or spinal cord. Cell replacement strategies should provide a basis for the development of new highly efficient symptomatic therapies for a broad spectrum of human neurological diseases. However, the paucity of suitable cell types for cell replacement therapy in patients suffering from neurological disorders has hampered the development of this promising therapeutic approach [1]. The recent finding that adult bone marrow contains neural crest-derived cells rebooted the cellular therapy challenges, as those cells can be easily isolated and can give rise to different type of mature neural cells. However, several points still need to be clarified before using those cells in such a cellular therapy protocols. In particular, one may ask whether the neuronal phenotypic plasticity of the bone marrow cells is an exclusive property of these neural crest-derived cells.
In early vertebrate development, the neural crest is specified in the embryonic ectoderm at the boundary of the neural plate and the ectoderm. Once specified, the neural crest cells (NCC) undergo a process of epithelial-to-mesenchymal transition (EMT) that will confer on them the ability to migrate. The EMT involves different molecular and cellular machineries and implies deep changes in cell morphology and in the type of cell surface adhesion and recognition molecules. After completing EMT, the NCC delaminate from the epithelial neural folds/neural tube and start migrating along characteristic pathways to differentiate into a wide variety of derivatives [2].
In 2000, Jiang et al. [3] developed a two-component genetic system based on Cre/lox recombination to indelibly label the entire mouse neural crest population at the time of its formation, and to detect its progeny at any time thereafter. In such a model, the fate of NCC was mapped in vivo by mating ROSA26 Cre reporter (R26R) mice, expressing β-galactosidase upon Cre-mediated recombination, with mice expressing Cre recombinase under the control of the Wnt1 promoter. Using this transgenic model, Sieber-Blum and Grim [4] demonstrated the presence of pluripotent neural crest-derived cells in adult hair follicles, Wong et al. [5] identified NCC in mouse adult skin and Nagoshi et al. [6] isolated NCC from adult bone marrow. Another mouse expressing the Cre recombinase under the control of the P0 promoter is also used in the same approach to map the NCC, and, in the bone marrow, both Cre-expressing mice have allowed the tagging of the same neural crest-derived cells [7–9].
In this paper, using the Wnt1-Cre/R26R double-transgenic mice model, as previously described, we confirmed the presence of neural crest-derived cells in adult bone marrow. As only a little information could be found on neural crest-derived cells in adult bone marrow, we decided to further characterize those cells by comparing them to the nestin-positive cell population initially described as a neurogenic population. Indeed, we demonstrated several years ago that only nestin-positive cells isolated from adult bone marrow could differentiate into functional neurons [10, 11]. Working with cell clones, we performed a direct comparison of neural crest stem cells (NCSC) and mesenchymal stem cells (MSC), both isolated from adult bone marrow. Altogether, this study highlighted the fact that bone marrow nestin-positive population was a mixed population, mainly composed of NCSC, but also containing few MSC. More surprisingly, we demonstrated that MSC were able to truly differentiate (without fusion process) into neural cells when placed in appropriate culture conditions.
Materials and methods
Animal care
Wnt1-Cre/R26R-LACZ double transgenic mice were used to confirm the presence of NCC in adult bone marrow and to discriminate NCSC clones from MSC clones. Transgenic green fluorescent protein (GFP) C57BL/6J mice as well as wild-type C57BL/6J mice (The Jackson Laboratory, Bar Harbor, Maine, USA, http://www.jax.org) were used to produce cerebellar granule neurons (CGNs). Adult (8–15 weeks old) rats (The Jackson Laboratory, http://www.jax.org) were used to compare nestin-positive and nestin-negative cell populations. Rodents were bred at the University of Liège Central Animal facility and euthanized in accordance with the rules set by the local animal ethics committee as well as the Swiss Academy of Medical Sciences.
Bone marrow stromal cell (BMSC) culture
Adult (8–15 weeks old) rat bone marrow was obtained from femoral and tibial bones by aspiration and was resuspended in 5 ml of Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen, Merelbeke, Belgium, http://www.invitrogen.com). Between 100 and 200 × 106 marrow cells were plated on 175-cm2 tissue culture flasks in DMEM added with 10% (v/v) fetal bovine serum (FBS; Invitrogen). After 24 h, the non-adherent cells were removed. Bone marrow cells from adult (8–15 weeks old) mice were obtained from femoral and tibial bones by aspiration and were resuspended in 5 ml of MesenCult Medium (StemCells Technologies, Grenoble, France, http://www.stemcell.com). After 24 h, non-adherent cells were removed. When the BMSCs became confluent, they were resuspended using 0.05% trypsin–ethylenediaminetetraacetic acid (EDTA) (Invitrogen) and then sub-cultured (750,000 cells/5 ml).
Preparation and culture of mouse cerebellar granule neurons
Mouse CGNs were prepared from 3-day-old GFP or wild-type C57BL/6J mice (The Jackson Laboratory, http://www.jax.org), [11]. Green mice express GFP under control of the β-actin promoter [11]. Wild-type CGNs were only used with NCSC clones as those clones would express LacZ, which was used to discriminate both cell types. Briefly, cerebella were removed and freed of meninges. They were then minced into small fragments and incubated at 37°C for 25 min in 0.25% trypsin and 0.01% DNAse (w/v, in a cation-free solution). Fragments were then washed with minimum essential medium (MEM; Invitrogen) supplemented with glucose (final concentration 6 g 1−1), 5 μg ml−1 insulin (Sigma-Aldrich, St. Louis, MO, USA, http://www.sigmaaldrich.com), 1 mM sodium pyruvate (Invitrogen) and 10% horse serum (Invitrogen). The potassium concentration was increased to 25 mM, while the sodium concentration was decreased in an equimolar amount (MEM-25HS). The dissociation was achieved mechanically by up-and-down aspirations in a 5-ml plastic pipette. The resulting cell suspension was then filtered on a 15-μm nylon sieve. Cells were then counted and diluted to a final concentration of 2.5 × 106 cells ml−1. The cell suspension was finally plated on a substrate previously coated with 0.1 mg ml−1 polyornithine. The cells were cultured for 24 h before any other experimental procedure was performed.
Clonal selection
Passage 5 BMSC (from Wnt1-Cre/R26R-LACZ double transgenic mice) have been seeded in a 96 wells plate at a dilution of 0.7 cell/well, in MesenCult Medium (Stem Cells Technologies). When cells reached confluence, they were dissociated with 0.05% trypsin–EDTA and sub-cultured at 150,000 cells ml−1.
Immunocytofluorescence
Briefly, cell cultures were fixed with 4% paraformaldehyde (PFA) for 10 min at room temperature, and then blocked with 10% normal donkey serum (NDS) and/or 3% bovine serum albumin (BSA) for 45 min. Anti-Sox10 (1:200; Affinity Bioreagents, CO, USA, http://www.antibodydirectory.com), anti-nestin (1:300; Novus Biologicals, Littleton, CO, USA, http://www.novusbio.com/), anti-GFAP (1:1,000; DakoCytomation, Glostrup, Denmark, http://www.dako.com), anti-Tuj1 (1:1,000; Covance, Princeton, NJ, USA, http://www.covance.com), anti-SMA (1:400; Sigma-Aldrich), anti-MAP2ab (1:1,000; Sigma-Aldrich), anti-TRP2 (1:400; Abcam, Cambrige, UK, http://www.abcam.com/), and anti-p75NTR (1:100; Millipore, Billerica, MA, USA, http://www.Millipore.com/) were used for 2 h at room temperature or overnight at 4°C. After four washes, fluorescein isothiocyanate—or rhodamine red-x-conjugated—secondary antibodies (1:500; Jackson Immunoresearch Laboratories) were incubated for 1 h at room temperature and finally, cell cultures were counterstained with Vectashield HardSet Mounting Medium with DAPI (Vector Laboratories, Burlingame, http://www.vectorlabs.com). Preparations were observed using an Olympus laser scanning confocal microscope (Olympus, Tokyo, http://www.olympus-global.com). The fraction of positive cells was determined by counting ten non-overlapping microscopic fields for each coverslip (with a minimum of three coverslips per experiment) in at least three separate experiments (n represented the number of experiments).
Other stainings
X-gal staining was performed on 2% PFA-fixed cells. Cells or bone sections were incubated for 2 h in PBS supplemented with 20 mM Tris (pH 7.4), 2 mM MgCl2, 0.02% NP-40, 0.01% Na-deoxycholate, 5 mM K3Fe(CN)6 (Sigma-Aldrich), 5 mM K4Fe(CN)6 (Sigma-Aldrich), and 1 mg ml−1 1-Methyl-3-indolyl-β-d-galactopyranoside (Sigma-Aldrich) in dimethylsulfoxide (DMSO). The reaction was stopped by phosphate-buffered saline (PBS) washes.
Functional characterization
Several protocols have been used to analyze the differentiating abilities of bone marrow NCC into smooth muscle cells, adipocytes, osteocytes, chondrocytes and melanocytes. Smooth muscle differentiation: Cells were incubated in DMEM/F12 supplemented with B27 (Invitrogen), Chick Embryo Extract 5% and 1 nM transforming growth factor β (TGF-β; PeproTech, London, UK, http://www.peprotech.com). Adipogenic differentiation: differentiation was induced by treatment with DMEM containing 0.5 mM 1-methyl-3-isobutylxanthine (Sigma-Aldrich), 1 μM dexamethasone (Sigma-Aldrich), 0.01 mg ml−1 bovine insulin, 0.2 mM indomethacin (Sigma-Aldrich). Cells were placed in the above adipocyte induction medium for 21 days. The differentiation was evaluated by accumulation of lipid vacuoles and staining with Oil Red O (Sigma-Aldrich) following fixation with 4% PFA. Melanocyte formation was obtained after 10 days in MEM containing 10% FBS, 50 ng ml−1 murine stem cell factor (mSCF; PeproTech) and 100 nM endothelin-3 (Sigma-Aldrich). Cells were fixed with 4% PFA and stained with an anti-TRP2 antibody. For osteogenic induction, cells were cultivated in StemXVivo Osteogenic media (R&D Sytems, Minneapolis, MN, USA, http://www.rndsystems.com). Osteogenic differentiation was measured using p-nitrophenyl phosphate, a substrate for alkaline phosphatase (Sigma-Aldrich). Level of alkaline phosphatase activity was detected by development of soluble yellow reaction product that may be read at 405 nm using a Thermo Labsystems Multiskan Ascent 354 (Lab Recyclers, Gaithersburg, MD, USA, http://www.labrecyclers.com). Chondrocyte formation was obtained after 1 month in DMEM containing 0.1 μM dexamethasone (Sigma-Aldrich), 1 mM sodium pyruvate (Invitrogen), 50 μg ml−1 ascorbic-2-phosphate acid (Sigma-Aldrich), 6.25 μg ml−1 transferin (Sigma-Aldrich), 6.25 μg ml−1 bovine insulin, 6.25 μg ml−1 selenic acid (Sigma-Aldrich), 5.35 μg ml−1 linoleic acid (Sigma-Aldrich), 1.25 mg ml−1 BSA and 10 ng ml−1 TGF-β3 (PeproTech). Pellets were fixed with 4% PFA, paraffin-embedded, cut as 5 μm sections and stained with toluidine blue. In each case, medium was refreshed every 3–4 days.
Neural differentiation ability
Several protocols have been used to differentiate MSC and NCSC into GFAP- or Tuj1-positive cells. (1) Serum-containing medium: neural differentiation has been monitored by cells in DMEM/F-12 supplemented with 10% FBS (Invitrogen) for 10 days. (2) Neurotrophin-containing medium: neural differentiation was observed after culture of cells in DMEM/F12 supplemented with B27 (Invitrogen), 1% FBS, 50 ng ml−1 brain-derived neurotrophic factor (BDNF; PeproTech), 50 ng ml−1 nerve growth factor (NGF; PeproTech) and 10 ng ml−1 neurotrophin-3 (NT-3; PeproTech) for 2 weeks. (3) Co-culture with mouse CGNs: 1,2500 NCSC or MSC were co-cultivated with CGNs (prepared as previously described), for 5 days in serum-free CGN culture medium.
Signaling pathway inhibition
For neural differentiation inhibition, two clones were separately co-cultivated with CGNs for 5 days, in the presence of 1 μM PD98059 (Sigma-Aldrich) and 1 μM SB431542 (Sigma-Aldrich) inhibitors dissolved in DMSO. Inhibitors were placed at day 0 of co-culture and medium supplemented with inhibitors was replaced after 3 days. Each inhibitor effect was compared to DMSO control conditions. Culture coverslips were processed to immunocytofluorescence and preparations were observed using an Olympus laser scanning confocal microscope (Olympus, Tokyo, Japan, http://www.olympus-global.com). The fraction of positive cells was determined by counting ten non-overlapping microscopic fields for each coverslip (with a minimum of three coverslips per experiment) in at least three separate experiments (n represented the number of experiments).
RNA extraction, RT-PCR analyses
Total RNA was prepared using the RNeasy total RNA purification kit (Qiagen, Valencia, CA, USA, http://www.qiagen.com). cDNA synthesis was carried out using Moloney-murine leukemia virus (MMLV) reverse transcriptase (Promega) and random hexamer primers (Promega), following the manufacturer’s instructions. PCR procedures and primers have been described in Glejzer et al. [9].
Microarray analysis
The RNA quality was assessed by the Experion automated electrophoresis system using the RNA StdSens Analysis Kit (Bio-Rad, Nazareth, Belgium, http://www.Bio-Rad.com). Four micrograms of total RNA were labeled using the GeneChip Expression 3′-Amplification One-Cycle Target Labeling Kit (Affymetrix, Santa Clara, CA, USA, http://www.affymetrix.com) following the manufacturer’s protocol. The cRNA was hybridized to GeneChip Mouse Genome 430 2.0 (Affymetrix) according to the manufacturer’s protocol. Briefly, double-stranded cDNA was synthesized from 4 μg of total RNA primed with a poly-(dT)-T7 oligonucleotide. The cDNA was used in an in vitro transcription reaction in the presence of T7 RNA polymerase and biotin-labeled modified nucleotides for 16 h at 37°C. Biotinylated cRNA was purified and then fragmented (35–200 nucleotides) together with hybridization controls and hybridized to the microarrays for 16 h at 45°C. Using Fluidics Station (Affymetrix), the hybridized biotin-labeled cRNA was revealed by successive reactions with streptavidin R-phycoerythrin conjugate, biotinylated anti-streptavidin antibody, and streptavidin R-phycoerythrin conjugate. The arrays were finally scanned with an Affymetrix/Hewlett-Packard GeneChip Scanner 3000 7G. The data were generated with the PLIER algorithm included in Affymetrix GeneChip Command Console Software (AGCC) and Expression Console. The probe sets have been filtered on signal log ratio (greater than 0.6 for up-regulated and less than −0.6 for downregulated transcripts) and on p value associated with the change status (<0.001 for up-regulated probe sets, >0.999 for down-regulated probe sets). To determine which pathways were significantly regulated, lists of expressed genes were uploaded in Ingenuity Pathway Analysis software (IPA 6.0; Ingenuity Systems, http://www.ingenuity.com). Microarray results from NCSC and MSC clones are accessible on GEO datasets/NCBI (GSE30419; http://www.ncbi.nlm.nih.gov/gds).
Dendrogramme
Dendrogramme was generated in an unsupervised analysis comparing expression array data of NCSC clones, MSC clones, with several expression array data available from the Gene Expression Omnibus database (GEO) http://www.ncbi.nlm.nih.gov/geo/. All samples from GEO datasets have been processed on Affymetrix Mouse Genome Expression Set 430 GeneChips. Normalization and data filtering were performed using BRB-ArrayTools software version 3.8.1 developed by Dr. Richard Simons and the BRB-ArrayTools Development Team, http://linus.nci.nih.gov./BRB-ArrayTools.html. We used the GCRMA algorithm as normalization step. Quartiles of each expression arrays were compared in a boxplot view. Medians, first and third quartiles were similar in each case (data not shown). This similarity allowed the comparison of the 118 arrays under the same analysis process. Background noise has been removed with the “Log Intensity variation” function of “BRB-ArrayTools” at a p value >0.05. The package “pvclust” from R-cran (Team, R.D.C., R: A Language and Environment for Statistical Computing; 2009) was used on the remaining filtered genes to build and test the architecture of each cluster of samples. “pvclust” is used for assessing the uncertainty in hierarchical cluster analysis. For each cluster in hierarchical clustering, p values are calculated via multiscale bootstrap resampling. This indicates how strong the cluster is supported by data. “pvclust” provides two types of p values: Approximately Unbiased (AU) p value in red and Bootstrap Probability (BP) value in green. AU p value, which is computed by multiscale bootstrap resampling, is a better approximation to unbiased p value than BP value computed by normal bootstrap resampling. We chose the most commonly used “Euclidean distance” as dissimilarity metric and three different methods of linkage (single, complete, average) to obtain dendrogram structures. The relevance of dendrograms architecture was then tested by data permutations. We set the multiscale boostrap resampling argument of “pvclust” at 1,000 permutations of genes to test those dendrograms. Only the “average linkage” method showed the best stable structure (Fig. 4).
2D-DIGE analyses and mass spectrometry
2D-DIGE proteomic analysis has been performed on proteins from rat MSC. Proteins were extracted in a lysis buffer containing 7 M urea (GE Healthcare, Chalfont St. Giles, UK, http://www.gehealthcare.com), 2 M thio-urea (GE Healthcare), 30 mM Tris (pH 8.5) (GE Healthcare) and 2% ASB14 (Sigma-Aldrich). The supernatant containing the extracted proteins was precipitated (2-D Clean-Up Kit; GE Healthcare) and amounts of resolubilized proteins were determined using RC-DC Protein Assay (Bio-Rad). Each 25 μg of sample protein was labeled with 200 pmol CyDye (GE Healthcare), either Cy3 or Cy5, and left for 30 min in the dark. The labeling reaction was stopped by adding 10 mM lysine for 10 min at 4°C. An internal standard was prepared by mixing equal quantities of all the experimental samples and was labeled with Cy2. Then, all the samples within the experiment were mixed in pairs together with 25 μg of the labeled internal standard and were separated by isoelectric focusing using pH 3–11 (24 cm) IPG strips in an Ettan IPGphor focusing system (GE Healthcare) in the first dimension. The following electrophoresis steps were successively applied: 8 h of rehydration, 1 h at 500 V, 1 h to 1,000 V (gradient), 3 h to 8,000 V (gradient) and 8 h 45 min at 8,000 V (step-and-hold). Before initiating the second dimension step, proteins in IPG strips were reduced for 15 min in an equilibration buffer (50 mM Tris–HCl (pH 8.8), 6 M urea, 30% glycerol, 2% SDS) containing 1% DTT and then they were alkylated in the same equilibration buffer containing 5% iodoacetamide. IPG strips were placed on top of classical 12.5% SDS-PAGE gels and the electrophoretic migration was completed in an Ettan Dalt apparatus (GE Healthcare) at 2.5 W/gel for 30 min, and then 25 W for 4 h. After scanning the gels in a Typhoon 9400 Laser Scanner (GE Healthcare) at three different wavelengths corresponding to the different CyDyes, 2-D gel analysis software (DeCyder version 6.5; GE Healthcare) was used for spot detection, gel matching and spot quantification relative to the corresponding spot in the internal standard. Protein spots that showed a significant variation in their abundance of at least twofold (Student’s t test, p < 0.05) were selected for further Biological Variation Analysis (BVA) and then they were automatically picked from the gels with the Ettan Spot Picker (GE Healthcare) and subjected to automatic tryptic digestion (PROTEINEER dp automated digester; Bruker Daltonics, Bremen, Germany, http://www.bdal.com). Gel pieces were washed three times in 50 mM NH4HCO3 followed by 50% ACN/50 mM NH4HCO3. Two other washes were carried out with 100% ACN to dehydrate the gels. In-gel digestion was performed with freshly activated trypsin (Roche, Basel, Switzerland, http://www.roche.com) at a concentration of 10 ng l−1 in 50 mM NH4HCO3/5% ACN. After rehydration of the gel pieces at 8°C for 60 min, tryptic digestion was carried out at 30°C for 4 h. The resulting digested peptides were extracted with 1% trifluoroacetic acid (TFA) for 30 min at 20°C with occasional shaking. A volume of 3 ml of protein digests was adsorbed for 3 min on Prespotted AnchorChip plates with α-Cyano-4-hydroxycinnamic acid (CHCA) as a matrix, using the PROTEINEER dp automat. Then the spots were briefly desalted with 10 mM dihydrogenoammonium phosphate in 0.1% TFA. MS fingerprints of the samples were acquired using the Ultraflex II MALDI-TOF–TOF mass spectrometer (Bruker Daltonics) in the mass range 700–3,500 Da. The Peptide Mass Fingerprinting (PMFs) were searched against the NCBI database. The variable and fixed modifications were methionine oxidation and cysteine carbamylation, respectively, with a maximum number of missed cleavages of 1. Mass precision tolerance error was set to 100 ppm. Peaks with the highest intensities, obtained in TOF/MS mode, were next analyzed by LIFT MS/MS. Proteins were identified with the Biotools 3.0 software (Bruker Daltonics) using the Mascot search engine (Matrix Science, Boston, MA, USA, www.matrixscience.com).
Electrophysiological recordings
All NCSC clones or MSC clones were pooled into NCSC or MSC mixed populations, keeping the same ratio of each clone. Mixed populations were than co-cultivated for 5–22 days with CGNs, as previously described. During recordings, cover slip was continuously perfused with artificial cerebrospinal fluid (ACSF; 137 mM NaCl, 5.4 mM KCl, 2 mM CaCl2, 22.2 mM d-glucose and HEPES; pH 7.4) at room temperature. ACSF and drug applications were performed using gravity and a BPS-8 valve control system (ALA Scientific, Westbury, NY, USA, http://www.alascience.com/). T^Yhen, 1 μM tetrodotoxin (TTX; Tocris Biosciences, Ellisville, MO, USA, http://www.tocris.com) and 20 mM tetraethylammonium (TEA; Sigma-Aldrich) were added to the ACSF to respectively block Na+ or K+ current. Neurons from clones were discriminated using an Axiovert microscope (Zeiss, Oberkochen, Germany, http://www.zeiss.de/). Pipettes were pulled on a P-87 micropipette puller (Sutter Instruments, Novato, CA, USA, http://www.sutter.com) using borosilicate glass capillary tubing (2.0 mm OD 1.16 mm ID; Hilgenberg, Malsfeld, Germany, http://www.hilgenberg-gmbh.com). The resistance of the electrodes was 5–8 MΩ when filled with the intracellular solution: 130 mM KCl, 2 mM CaCl2, 2 mM HEPES, 2.5 mM ATP-Mg, 2.5 mM ATP-Na2, 10 mM EGTA and 11.1 mM d-glucose; pH 7.4. Non-fluorescent neurons (from clones, as CGN were originated from GFP-mice) were sealed at a gigaohm and placed in whole-cell configuration. Membrane potentials and currents were recorded using an EPC9 amplifier (HEKA, Lambrecht/Pfalz, Germany, http://www.heka.com/) connected to Patchmaster software (HEKA). Liquid junction potentials were corrected. Only recordings in which the series resistance was lower than 30 MΩ and remained stable (variations ≤20%) were used. No compensation of the series resistance was performed.
Statistical analysis
Data were analyzed statistically using Statistica 9 program (StatSoft, Tulsa, OK, USA, http://www.statsoft.com). Data are reported as mean ± standard deviation, with the number of experiments (n) between parentheses. Level of statistical significance was set at p < 0.05.
Results
Transcriptomic comparison of rat nestin-negative versus nestin-positive bone marrow stromal cells
We previously demonstrated that adult rat nestin-positive BMSC isolated from adult bone marrow were able to differentiate into excitable neurons, when co-cultured with mouse CGNs [11]. The proportion of nestin positive-cells in culture was quite low at passage 0, but would increase with reduced cell confluence [12] and higher passage numbers [10], until reaching a plateau (75% nestin-positive cells) at passage 7. As it was not clear if nestin-positive and nestin-negative cells were different cell populations or the same cells at different maturation stages, we decided to further characterize those two types of cells. We compared passage 4 BMSC as nestin-negative cell population and passage 15 BMSC as nestin-positive cell population, both cell types being cultivated for 48 h in serum-free medium before analyses, as previously described [10]. Microarray analyses revealed that nestin-negative and nestin-positive BMSC expressed around 20,000 genes with 379 genes that were significantly different (Supplementary data, Table S1). Using Ingenuity Pathway Software (IPA 6.0), we classified all expressed genes according to their relevance to cell fate specificity. A total of five categories of genes have been described (stem cell, neural, mesenchymal, hematopoietic, and endothelial genes). As we can observe in Fig. 1a and Fig. S1 (Supplementary data), when compared to nestin-negative cells, nestin-positive cells over-express genes that characterize stem cell and neural cell states and decrease their level of expression of genes involved in mesenchymal, hematopoietic or endothelial cell fate. Likewise, we compared genes involved in signaling pathways mainly expressed by nestin-positive cells compared to nestin-negative cells. Again, using Ingenuity Pathway Software, we classified all expressed genes in eight families of signaling pathway genes: Wnt/Fzd, Notch/Delta, Insulin, NF-κB, MapK, PI3K, Jak/Stat, and TGFbeta. As observed on Fig. 1b and Fig. S2 (Supplementary data), the three most regulated gene families were Notch/Delta, Insulin, and NF-κB. Although those results were interesting, it was not possible to rigorously answer with the question if nestin-positive and nestin-negative BMSC were different cell populations or cells with different maturation stages. We consequently decided to have a closer look at the two cell populations on a proteomic level.
Proteomic comparison of rat nestin-negative (P4) versus nestin-positive (P15) bone marrow stromal cells
Proteomic analyses using the 2D-DIGE technology revealed 131 spots with different abundances (minimum twofold-change; Fig. 1c), and identified (by mass spectrometry) 71 proteins that were significantly over-expressed in nestin-positive compared to nestin-negative MSC. As observed on Table S2 (Supplementary data), more than 35% of those proteins are implicated in cell cycle regulation (DARS, ANXA5, ATIC, CALD1, DPYSL2, FTL, HSP90AB1, NEDD4, P4HA1, PDIA6, POLA1, RSP6KA1, SH3GL1, TPM3, VAMP1, CAPNS1, MSN, PAK2, TXNL1, PDIA3, and PRDX3). Although those results would suggest that nestin-positive cells had a more proliferative phenotype and thus were at a more immature stage than nestin-negative cells, it was still not possible to answer the question of different cell populations or different maturation stages. One of the main reasons for this was probably the fact that the data contained a lot of falsely unregulated genes or proteins due to the heterogenous cell populations as nestin-positive cell population (high passages) would still contain 25% of nestin-negative cells and vice versa. We consequently decided to use a different approach to answer that question and use transgenic mice to work with a more restrictive population. As several results pointed out that nestin-positive BMSC and NCSC shared common characteristics (i.e., SOX10, ErbB3, and p75NTR over-expression), we formulated the hypothesis that nestin-positive cells as observed in our cultures could actually be neural crest-derived cells.
Confirmation of the presence of neural crest-derived stem cells in mouse adult bone marrow
With a paradigm similar to the one used by Nagoshi et al. [6], who recently demonstrated the presence of NCSC in adult bone marrow, we verified our hypothesis using a double transgenic model (Wnt1-Cre/R26R mice) to track NCSC. BMSC were first extracted from Wnt1-Cre/R26R-LacZ adult mice and cultured in MesenCult® medium. Interestingly, in those culture conditions, the proportion of LacZ expressing cells increased from 5.42 ± 1.68% of cells at passage 2 (P2) to 41.55 ± 16.26% of cells at passage 6 (P6), similarly to what was observed with adult rats and adult mice nestin-positive BMSC (p = 0.002, n=3, repeated measure ANOVA followed by Tukey–Kramer’s post hoc test; Fig. 2a–b). In order to be able to rigorously compare NCSC with MSC, both isolated from adult bone marrow, we decided to generate clonal cultures using β-galactosidase expression as a reporter gene to discriminate NCSC clones from MSC clones.
Clonal analyses of NCSC versus MSC from adult bone marrow
Single cells, from passage 5 BMSC, were placed in a 96-well plate in MesenCult medium. In those conditions, 1.2% of cells were able to proliferate. Five NCSC clones (β-galactosidase-positive cells) and six MSC clones (β-galactosidase-negative cells) have been maintained in long-term culture (more than 25 passages), showing their stable self-renewal ability. However, all characterization described thereafter have been performed within the first ten passages after clonal selection. We first characterized those clones for their expression of the classical neural crest markers Sox10, p75NTR, and nestin. All NCSC clones were 100% positive for Sox10, p75NTR and Nestin (Fig. 2c–e). On the other hand, MSC clones were Sox10-negative, 20.2 ± 10.8% of cells (in each clone) were nestin-positive and were weakly positive for p75NTR (Fig. 2g−i). As we rigorously followed the growth of our clones, we were sure that each clone was derived from a single cell; thus, heterogenous nestin expression by MSC clones was probably due to a variable sensitivity to inductive or repressive factors. Indeed, the level of nestin-positive cells increased to around 90% when those cells were placed in serum-free condition (Fig. 2j) similar to what we initially described with high passage non-clonal adult rat and mice BMSC [10]. This sensibility to serum for nestin expression is also a difference between NCSC and MSC, as there was no effect on NCSC clones placed in serum-free medium (Fig. 2f). Those results and the increase of LacZ expression in high passage numbers BMSC cultures strongly suggested that nestin-positive MSC populations, initially described in 2003 [10], were thus a mixed population of NCSC and MSC, with a majority of NCSC at higher passages. Moreover, those results have been confirmed on general population of BMSC culture isolated from Wnt1-Cre/R26R-LacZ mice, showing that nestin-positive cells were mainly composed of β-galactosidase positive cells, but also containing few β-galactosidase negative cells (data not shown).
Multipotency of NCSC compared to MSC
We then analyzed NCSC and MSC clones abilities to differentiate into mesenchymal cells. NCSC clones were able to differentiate into chondrocytes (Fig. 3b) and melanocytes (Fig. 3d), but not into adipocytes (Fig. 3a), smooth muscle cells (Fig. 3c), or osteocytes (Fig. 3i), while MSC were able to differentiate into adipocytes (Fig. 3e), osteocytes (Fig. 3i), chondrocytes (Fig. 3f), and smooth muscle cells (Fig. 3g). The fact that we could not differentiate NCSC clones into adipocytes and smooth muscles was quite surprising, as we previously demonstrated that NCSC were also able to differentiate into adipocytes and smooth muscle cells when cultivated in presence of Wnt1 and BMP2 [9], two factors described for maintenance and proliferation of NCSC. Consequently, NCSC clones were pre-treated with Wnt1 and BMP2 for 1 week before inducing their differentiation [13]. Interestingly, those clones then became able to differentiate into adipocytes (Fig. 3j); however, we were still unable to differentiate them into smooth muscles (data not shown). We then analyzed the neural differentiation abilities of NCSC clones compared to MSC clones. We first placed those cells in serum-containing medium (Fig. 3k–p) for spontaneous differentiation, then in neurotrophin-containing medium for specific differentiation (Fig. 3q, r). In those conditions, only NCSC clones were able to differentiate into Tuj1-positive cells. However, both types of clones were able to differentiate into GFAP-positive cells, although this phenomenon was more frequently observed in NCSC clones. As we previously demonstrated that BMSC were able to differentiate into functional neurons when co-cultivated with CGNs [11], we analyzed the abilities of NCSC and MSC clones to differentiate into Tuj1-positive cells using a co-culture protocol. In those conditions, NCSC (Fig. 4a) and MSC (Fig. 4b) were able to differentiate into Tuj1-positive cells after 5 days. At this stage of the study, two hypotheses could explain the absence of neuronal differentiation of MSC in absence of co-culture: (1) several studies have demonstrated that BMSC were able to fuse with neurons to adopt their characteristics [14], and (2) it is possible that neurotrophins or serum were not sufficient factors to orient MSC toward a neuronal fate, and that other factors expressed by CGNs would be necessary. To test the first hypothesis, we cultivated NCSC or MSC clones on PFA-fixed CGNs, in the presence of CGNs conditioned medium, as previously described [11]. Surprisingly, under those conditions, we observed Tuj1-positive cells derived from NCSC as well as MSC clones, suggesting that some MSC were also able to truly differentiate into neural cells (Fig. 4c–d). To rule out the possible extinction of GFP in PFA-fixed CGNs, we placed them for 5 days in conditioned medium in the absence of clones, and thus confirmed their stable GFP level (data not shown). We consequently concluded that MSC were not sensitive to neurotrophin stimulation, which could be partially explained by their low amount of p75NTR expression. Finally, to complete the characterization of neuronal differentiation, we performed electrophysiological recordings on NCSC and MSC clones. Using fluorescent microscopy, we selected cells that exhibited a neuron-like shape (rounded cell body with extended processes), and were clearly GFP negative (see “Materials and methods”). Whole-cell patch-clamp recordings were obtained from 49 MSC and 43 NCSC that had been co-cultured with CGNs for 5–20 days. No significant differences were observed in term of resting membrane potentials over the time or between cell types: MSC Vrest −35 ± 4 mV and NCSC Vrest −37 ± 5 mV. The presence of voltage-gated channels was assessed by applying hyperpolarizing and depolarizing voltage steps to voltage-clamped cells, from a holding potential of −50 mV. Throughout the culture period, 100% of MSC and NCSC showed outward currents that were blocked by tetraethylammonium (TEA, 20 mM), indicating the presence of voltage-gated potassium channels (data not shown). However, 2% of MSC and no NCSC showed tetrodotoxin-sensitive (TTX, 1 μM), fast inward currents, indicating the presence of voltage-gated sodium channels (Fig. 4e). Consistent with the occurrence of voltage-gated sodium and potassium currents, injection of positive current pulses in current-clamp mode elicited action potentials in 2% of MSC cells (Fig. 4e), whereas no action potentials could be observed in NCSC. Finally, the expression of neuron-specific cytoskeletal proteins MAP2ab, which was absent after 5 days, was observed after 12 days of co-culture in both MSC and NCSC clones (Fig. 4f).
Transcriptomic comparison of NCSC versus MSC clones
To finalize the characterization of NCSC and MSC clones, we performed microarray analyses on those two sets of clones. In this case, around 20,000 genes were expressed by NCSC and MSC clones with 3,169 genes that were significantly up- or down-regulated between the two sets of clones (Supplementary data, Table S2). We classified those genes into cell fate gene families (Fig. 5c). As expected, NCSC clones would mainly over-express neural genes and down-express mesenchymal and endothelial genes (Supplementary data, Fig. S3). We confirmed the differential expression of several genes between both types of clonal populations by semi-quantitative RT-PCR. NCSC as well as MSC clones were negative for oct4, nanog, rex1, pax3, pax6, sox1, msl1, twist1, and wnt1 (data not shown), but positive for Notch1, nestin, hes1, sox2, CXCR4, p75NTR, sox10, id2, snail1, ngn1, and foxd3 (Fig. 5b). All expressed genes seemed to be over-expressed in NCSC, except snail1 and CXCR4, which were down-regulated. We also compared our microarray results with microarrays data obtained in other studies with different types of cells including cranial NCSC (isolated from embryos), embryonic fibroblasts, MAPC, ES-derived neurons, etc., and built a dendrogram reflecting the closeness of origin of the different cell types (Fig. 5a). As a result, MSC clones were still regarded as the closest cell type to the NCSC clones, followed by NCC isolated from head and neck region of embryos and neurons obtained from ES cells. On the other hand, developing heart cells as well as adipose cells shared lesser similarities with NCSC as well as with MSC clones.
Finally, looking at signaling pathways (Fig. 6a; Supplementary data, Fig. S4), genes families that were the most regulated in NCSC clones compared to MSC clones were the TGFβ and MAPK gene families. To test if these two pathways were implicated in neural differentiation of NCSC clones, we co-cultivated those clones with CGNs, in the presence of MAP/ERK inhibitor (PD98059) or TGFβ inhibitor (SB431542). In those conditions, we observed a significant decrease of the number of Tuj1-positive cells treated with the MAP/ERK inhibitor as only 3.7 ± 1.3% Tuj1-positive cells were found (Fig. 6b–e), instead of 10.6 ± 1.9% Tuj1-positive cells (control condition). No significant difference was observed after treatment with TGF-β inhibitor as 11.1 ± 3.5% Tuj1-positive cells were found. Those results suggest that the MAP/ERK pathway could be one of the main signaling pathways directing NCSC toward a neuronal fate.
Discussion
Several studies have already reported the presence of NCSC in adult bone marrow [6, 8, 9]. Those cells could be good candidates for use in cellular therapy approaches to improve symptoms in various neurological disorders, as they are able to differentiate into neural cells and are found in an easy-access location, allowing autologous graft procedures. However, little is known about their characteristics, especially in comparison with MSC. In this study, we first analyzed the nestin-positive cell population isolated from adult rat bone marrow. Indeed, we initially described this population as the neurogenic population of adult bone marrow, since only those cells were able to differentiate into functional neurons [11]. However, given that our nestin-positive cell population was not pure (75% of BMSC were nestin-positive in the best conditions), it was difficult to identify specific markers for this population regarding the nestin-negative cells. This was also emphasized by the fact that in a transcriptomic approach, we found that only 379 genes on a total of 20,000 were up- or down-regulated between the two populations.
Then, we formulated the hypothesis that this nestin-positive population could actually be constituted by neural crest-derived cells. However, this hypothesis was incorrect as clonal analyses revealed that the nestin-positive cell population isolated from adult bone marrow was a mixed population of NCSC and MSC. Noteworthy, the regulation of nestin expression was different between MSC and NCSC as serum was able to repress this expression only in MSC, while no serum effect was observed on NCSC. A similar phenomenon has already been described for glial precursor cells in which serum (through TGFβ factors) inhibited nestin expression [15]. Moreover, we previously demonstrated that thrombin was able to up-regulate nestin expression by radial glial cells, but decreased the nestin expression in MSC cell population from bone marrow, indicating that the regulation of nestin expression could be finely modulated in various conditions and/or cell types [12].
Analyzing the mesenchymal differentiation abilities between those two cell types, it appeared that NCSC were able to differentiate into chondrocytes and melanocytes, while MSC were able to differentiate into adipocytes, chondrocytes, and smooth muscles. However, when pre-treated with Wnt1 and BMP2 factors, NCSC acquired the ability to differentiate into adipocytes. Those results were consistent with a recent study realized by John et al., in which Sox10-positive neural-crest derived progenitors were found to be unable to differentiate into adipocytes [16]. Indeed John and collaborators showed that TGFβ1 induced a switch in neural to mesenchymal potential in NCSC. Similarly, several studies have demonstrated that three main classes of signals: Wnts, BMP2/BMP4, and TGFβ1,2,3, directly influence the production of particular neural crest cell fates [17]. Remarkably, we failed to differentiate NCSC into smooth muscle cells. A couple of previous studies demonstrated that NCSC isolated from adult bone marrow could give rise to smooth muscle cells [6–8]. Both studies used Wnt1-Cre/EGFP transgenic mice and cell sorting to isolate NCSC from adult bone marrow based on their EGFP expression. EGFP-positive population was then placed in unspecific conditions (10% serum containing medium) and smooth muscle differentiation was evaluated after few days. In both cases, only a few SMA-positive cells were observed showing a restrictive capacity of differentiation into smooth muscle. Moreover, none of those studies confirmed the EGFP-expression of SMA-positive cells, which could not rule out a small contamination of NCSC population by MSC. Moreover, a recent study demonstrated that Foxd3 expression by NCSC maintain neural potential and repress mesenchymal fate [22]. RT-PCR analyses confirmed a strong level of expression of Foxd3 gene in NCSC clones compared to MSC clones (Fig. 5), which could also partially explained the absence of smooth muscle differentiation.
Looking at the neural differentiation abilities of NCSC and MSC clones, we observed that NCSC were able to differentiate into GFAP- and Tuj1-positive cells in serum-containing medium or in neurotrophins-containing medium, as well as in co-culture conditions with CGNs. However, MSC were able to differentiate into GFAP- or Tuj1-positive cells only in the co-culture condition. It is interesting to mention that NGF, BDNF, and NT3 receptors are the tyrosine kinase receptors, TrkA, TrkB, and TrkC, but also the low affinity nerve growth factor receptor p75NTR [18]. Microarray results revealed no expression of Trk receptors by MSC and a low expression level of p75NTR, which could explain the absence of effect of neurotrophins on MSC. Those receptors were expressed in NCSC and the signaling pathway that is recruited by these receptors in NCSC could be the MAPK pathway, as we demonstrated the genes belonging to this signaling pathway were the most up-regulated in NCSC clones and its inhibition significantly decreased their neuronal differentiation.
As mentioned above, the only way to differentiate MSC into neural cells was the co-culture protocol. To rule out the possibility of cell fusion events, we co-cultivated NCSC as well as MSC on PFA-fixed CGNs, in the presence of medium conditioned by these CGNs. Under those conditions, both cell types were able to differentiate into GFAP- or Tuj1-positive cells, suggesting that both cell types were truly able to differentiate into neural cells. More surprisingly, only MSC were able to fire action potentials in co-culture conditions, even if both cell populations showed some maturation signs. Indeed, some NCSC as well as some MSC would express MAP2ab after 12 days of co-culture; however, MAP2ab-positive cells were in a minority. The absence of action potentials in NCSC would therefore be related to a inappropriate differentiation protocol that could not lead to a full maturation of NCSC or even MSC into functional neurons.
On the other hand, MSC were found to be able to differentiate into neuronal cells in the presence of CGNs, suggesting that CGNs expressed factors that are mandatory to direct MSC toward a neuronal fate. Moreover, at least one of those factors is linked to the CGN, membrane as conditioned medium alone was not able to induce their neuronal differentiation. A recent publication revealed that Wnt1 factor induces Tlx3 expression, which was correlated with neuronal differentiation ability of MSC [19]. Wnt1 is a developmentally important gene involved in intercellular signaling that is expressed by CGNs in newborn mice [20]. Recent publications showed that Frizzled receptors FZD2, 3 and 4 were able to bind Wnt1 [21]. Our microarray results indicate that MSC expressed FZD1, 2, 5, 7, and 8, but not FZD3 and 4 receptors. However, Wnt1 factor seemed to be necessary (but not sufficient) to induce neuronal differentiation of MSC, as Wnt1-treated cells did not spontaneously differentiate into neuronal cells when placed in DEM/F12 medium (data not shown).
In conclusion, this study demonstrated that the putative bone marrow-derived nestin-positive population, which was able to differentiate into functional neurons, was a mixed population, mainly composed of NCSC, but also containing few MSC. More surprisingly, we demonstrated that bona fide MSC were able to truly differentiate (without fusion process) into neural cells when placed in appropriate culture conditions that could depend on Wnt signaling pathway activation. However, an interesting question, that remains pending, is the phenotype of the two types of neurons obtained from MSC and NCSC, especially regarding their abilities to synthesize neurotransmitters since this constitutes an essential characteristic in a perspective of cellular therapy for various neurological diseases.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Acknowledgments
This work was supported by a grant from the Fonds National de la Recherche Scientifique (FNRS) of Belgium, by a grant of the Action de Recherche Concertée de la Communauté Française de Belgique, by the Belgian League against Multiple Sclerosis associated with the Leon Fredericq Foundation, and by the Swiss National Science Foundation. P.L. is a senior research associate of the FNRS. A.G. is a Marie Curie Host Fellow for Early Stage Research Training, EURON 020589 within the 6th FP of the EU, Marie Curie Actions - Human Resources and Mobility. Normalization and data filtering were performed using BRB-ArrayTools software version 3.8.1 developed by Dr. Richard Simons and BRB-ArrayTools Development Team http://linus.nci.nih.gov./BRB-ArrayTools.html. Patricia Ernst and Alice Marquet also provided technical assistance to this study. Finally, we would like to thanks Professor Vincent Seutin who gave us the opportunity to use his electrophysiological platform. Finally, we would like to thanks Dr Ormenese and the GIGA plateform of flow cytometry and cell imaging for their valuable advises and technical support.
Footnotes
S. Wislet-Gendebien and E. Laudet contributed equally to this work
Change history
5/8/2021
A Correction to this paper has been published: 10.1007/s00018-021-03848-0
References
- 1.Kim SU, de Vellis J. Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res. 2009;87:2183–2200. doi: 10.1002/jnr.22054. [DOI] [PubMed] [Google Scholar]
- 2.Kalcheim C, Burstyn-Cohen T. Early stages of neural crest ontogeny: formation and regulation of cell delamination. Int J Dev Biol. 2005;49:105–116. doi: 10.1387/ijdb.041949ck. [DOI] [PubMed] [Google Scholar]
- 3.Jiang X, Rowitch DH, Soriano P, et al. Fate of the mammalian cardiac neural crest. Development. 2000;127:1607–1616. doi: 10.1242/dev.127.8.1607. [DOI] [PubMed] [Google Scholar]
- 4.Sieber-Blum M, Grim M, Hu YF, et al. Pluripotent neural crest stem cells in the adult hair follicle. Dev Dyn. 2004;231:258–269. doi: 10.1002/dvdy.20129. [DOI] [PubMed] [Google Scholar]
- 5.Wong CE, Paratore C, Dours-Zimmermann MT, et al. Neural crest-derived cells with stem cell features can be traced back to multiple lineages in the adult skin. J Cell Biol. 2006;175:1005–1015. doi: 10.1083/jcb.200606062. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Nagoshi N, Shibata S, Kubota Y, et al. Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. Cell Stem Cell. 2008;2:392–403. doi: 10.1016/j.stem.2008.03.005. [DOI] [PubMed] [Google Scholar]
- 7.Fujiwara K, Mochida S, Matsui A, et al. Fulminant hepatitis and late onset hepatic failure in Japan. Hepatol Res. 2008;38:646–657. doi: 10.1111/j.1872-034X.2008.00322.x. [DOI] [PubMed] [Google Scholar]
- 8.Morikawa S, Mabuchi Y, Niibe K, et al. Development of mesenchymal stem cells partially originate from the neural crest. Biochem Biophys Res Commun. 2009;379:1114–1119. doi: 10.1016/j.bbrc.2009.01.031. [DOI] [PubMed] [Google Scholar]
- 9.Glejzer A, Laudet E, Leprince P, et al. Wnt1 and BMP2: two factors recruiting multipotent neural crest progenitors isolated from adult bone marrow. Cell Mol Life Sci. 2011;68:2101–2114. doi: 10.1007/s00018-010-0558-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wislet-Gendebien S, Leprince P, Moonen G, et al. Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells. J Cell Sci. 2003;116:3295–3302. doi: 10.1242/jcs.00639. [DOI] [PubMed] [Google Scholar]
- 11.Wislet-Gendebien S, Hans G, Leprince P, et al. Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype. Stem Cells. 2005;23:392–402. doi: 10.1634/stemcells.2004-0149. [DOI] [PubMed] [Google Scholar]
- 12.Wautier F, Wislet-Gendebien S, Chanas G, et al. Regulation of nestin expression by thrombin and cell density in cultures of bone mesenchymal stem cells and radial glial cells. BMC Neurosci. 2007;8:104. doi: 10.1186/1471-2202-8-104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kleber M, Lee HY, Wurdak H, et al. Neural crest stem cell maintenance by combinatorial Wnt and BMP signaling. J Cell Biol. 2005;169:309–320. doi: 10.1083/jcb.200411095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature. 2003;425:968–973. doi: 10.1038/nature02069. [DOI] [PubMed] [Google Scholar]
- 15.Sakai Y, Rawson C, Lindburg K, et al. Serum and transforming growth factor beta regulate glial fibrillary acidic protein in serum-free-derived mouse embryo cells. Proc Natl Acad Sci USA. 1990;87:8378–8382. doi: 10.1073/pnas.87.21.8378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.John N, Cinelli P, Wegner M, et al. Transforming growth factor beta-mediated Sox10 suppression controls mesenchymal progenitor generation in neural crest stem cells. Stem Cells. 2011;29:689–699. doi: 10.1002/stem.607. [DOI] [PubMed] [Google Scholar]
- 17.Dorsky RI, Moon RT, Raible DW. Environmental signals and cell fate specification in premigratory neural crest. Bioessays. 2000;22:708–716. doi: 10.1002/1521-1878(200008)22:8<708::AID-BIES4>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
- 18.Cragnolini AB, Huang Y, Gokina P, et al. Nerve growth factor attenuates proliferation of astrocytes via the p75 neurotrophin receptor. Glia. 2009;57:1386–1392. doi: 10.1002/glia.20857. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Kondo T, Matsuoka AJ, Shimomura A, et al. Wnt signaling promotes neuronal differentiation from mesenchymal stem cells through activation of Tlx3. Stem Cells. 2011;29:836–846. doi: 10.1002/stem.624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Fu Y, Tvrdik P, Makki N, et al (2011) Precerebellar cell groups in the hindbrain of the mouse defined by retrograde tracing and correlated with cumulative Wnt1-Cre genetic labeling. Cerebellum (in press) [DOI] [PubMed]
- 21.Williams JM, Oh SH, Jorgensen M, et al. The role of the Wnt family of secreted proteins in rat oval “stem” cell-based liver regeneration: Wnt1 drives differentiation. Am J Pathol. 2010;176:2732–2742. doi: 10.2353/ajpath.2010.080486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Mundell NA, Labosky PA. Neural crest stem cell multipotency requires Foxd3 to maintain neural potential and repress mesenchymal fates. Development. 2011;138:641–652. doi: 10.1242/dev.054718. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.